Ipswich Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Ipswich Investment Management's REGN Position: Q2 2026 in Review
Ipswich Investment Management sold out of Regeneron Pharmaceuticals (REGN) in Q2 2026, closing a stake of 264 shares — an estimated $204K sold.
Ipswich Investment Management first reported a position in REGN in Q3 2013 and held it in 17 quarters. The position peaked at $306K in Q2 2015. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Ipswich Investment Management reported no remaining Regeneron Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Ipswich Investment Management sold 264 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $204K.
- Ipswich Investment Management first reported a position in Regeneron Pharmaceuticals in Q3 2013 and held it in 17 quarters.
- Ipswich Investment Management's Regeneron Pharmaceuticals position peaked at $306K in Q2 2015.
- 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Ipswich Investment Management's 13F filing for Q2 2026, filed 16 Jul 2026.